Lauren A Peters, PhD

img_Lauren A Peters
ADJUNCT ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Research Topics
Autoimmunity, Bioinformatics, Computational Biology, Drug Design and Discovery, Genomics, Immune Deficiency, Inflammation, Inflammatory Bowel Disease (IBD), Mucosal Immunology

BA, Boston University

MA, Columbia University

PhD, Icahn School of Medicine at Mount Sinai

Publications

Selected Publications

Inflammation rewires the enteric nervous system through neurogenic monocyte recruitment. Sravya Kurapati, Changsik Shin, Krisztina Szabo, Yu Liu, Azree Z. Ashraf, Balazs Koscso, Chinmayee Dash, Katherine L. Kruckow, Leonardo E. Navarro, Amanda M. Clark, Monalee Saha, Sushma Nagaraj, Wenhui Wang, Jun Zhu, Kevin Brown, Travis Thomson, Natalia Shulzhenko, Andrey Morgun, Christina E. Baer, Shanthi Srinivasan, Subhash Kulkarni, Pankaj J. Pasricha, Lauren A. Peters, Milena Bogunovic. Journal of Experimental Medicine

A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients. Lauren A. Peters, Joshua R. Friedman, Aleksandar Stojmirovic, Jacob Hagen, Sander Houten, Tetyana Dodatko, Mariana P. Amaro, Paula Restrepo, Zhi Chai, J. Rodrigo Mora, Holly A. Raymond, Mark Curran, Radu Dobrin, Anuk Das, Huabao Xiong, Eric E. Schadt, Carmen Argmann, Bojan Losic. Communications Biology

Biopsy and blood-based molecular biomarker of inflammation in IBD. Carmen Argmann, Ruixue Hou, Ryan C. Ungaro, Haritz Irizar, Zainab Al-Taie, Ruiqi Huang, Roman Kosoy, Swati Venkat, Won Min Song, Antonio F. Di'narzo, Bojan Losic, Ke Hao, Lauren Peters, Phillip H. Comella, Gabrielle Wei, Ashish Atreja, Milind Mahajan, Alina Iuga, Prerak T. Desai, Patrick Branigan, Aleksandar Stojmirovic, Jacqueline Perrigoue, Carrie Brodmerkel, Mark Curran, Joshua R. Friedman, Amy Hart, Esi Lamousé-Smith, Jan Wehkamp, Saurabh Mehandru, Eric E. Schadt, Bruce E. Sands, Marla C. Dubinsky, Jean Frederic Colombel, Andrew Kasarskis, Mayte Suárez-Fariñas. Gut

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Peters has not yet completed reporting of industry relationships or has no industry relationships to report.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.